There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC A61K31/5377
Pages in category "CPC A61K31/5377"
The following 118 pages are in this category, out of 118 total.
1
- 18289823. COMPOSITIONS AND METHODS OF TISSUE REGENERATION THERAPY simplified abstract (The Regents of the University of California)
- 18483651. Tricyclic Compounds and their Uses simplified abstract (Novartis AG)
- 18612909. LASER AND BCL-2 INHIBITORS COMBINATION TO TREAT SOLID TUMORS simplified abstract (Board of Regents, The University of Texas System)
- 18727136. TLR7/8-ANTAGONIST FOR TREATING SJÖGREN'S SYNDROME OR MIXED CONNECTIVE TISSUE DISEASE (Novartis AG)
- 18837125. USE OF MELANOCORTIN-4 RECEPTOR AGONIST IN PREVENTING OR TREATING RARE GENETIC OBESITY DISEASE (LG CHEM, LTD.)
- 18883386. USE OF A PIKFYVE INHIBITOR IN COMBINATION WITH IMMUNOTHERAPY (The Regents of the University of Michigan)
- 18938730. IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
2
- 20250152598. Method For Treating Cancer (Epizyme, Inc.)
- 20250152598. Method Treating Cancer (Epizyme, .)
- 20250161317. Molidustat Formulations Met (ELANCO US .)
- 20250161318. Solid Dispersions Containing Ap (ABBVIE .)
- 20250161319. Use Hpk (ASCLEPIEION PHARMACEUTICAL .,)
- 20250161320. Covalent Inhibitors Men (BIOMEA FUSION, .)
- 20250170137. Compositio (CHONG KUN DANG PHARMACEUTICAL .)
- 20250170138. Aryl-or Heteroaryl-substituted B (Epizyme, .)
- 20250177407. Rivaroxaban Dosing (Closed Loop Medicine .)
- 20250177408. Inhibitor (ETERN BIOPHARMA (SHANGHAI) ., .)
- 20250177409. Combination Therapy Pi3k I (MEI Pharma, .)
- 20250177410. Combination Therapie (MIRATI THERAPEUTICS, .)
- 20250177411. Oral Liquid Formulat (Liqmeds Worldwide Limited)
- 20250186451. Methods Tre (Otsuka Pharmaceutical ., .)
- 20250186452. Novel Use Quinolin (TARAPEUTICS SCIENCE .)
- 20250186453. Combination Therapie (Mirati Therapeutics, .)
- 20250186454. Methods (LAPKO , dba AFECTA PHARMACEUTICALS)
- 20250195532. Nov (The Curators of the University of Missouri)
- 20250205244. Methods Treating Migr (4E Therapeutics, .)
- 20250213581. Combination Therapy (Totus Medicines .)
- 20250228861. Cancer Treatments Using Mta-coopera (AMGEN .)
- 20250228862. Methods Using Atr (Repare Therapeutics .)
- 20250228863. Methods Pro (GLOBAL CANCER TECHNOLOGY, .)
- 20250228864. Therapies Treatm (Gilead Sciences, .)
- 20250228865. Compounds Enhancin (Sanofi US Services .)
- 20250228866. Crystalline Form O (Vividion Therapeutics, .)
- 20250228867. Methods Use Emu (Heron Therapeutics, .)
A
- AcuraStem, Inc. Patent Application Trends in 2024
- Amgen Inc. Patent Application Trends in 2024
- AMGEN INC. Patent Application Trends in 2025
- ASTEX THERAPEUTICS LIMITED Patent Application Trends in 2024
- AstraZeneca AB Patent Application Trends in 2024
- AstraZeneca AB Patent Application Trends in 2025
- Athos Therapeutics, Inc. Patent Application Trends in 2024
B
- Bayer Aktiengesellschaft Patent Application Trends in 2025
- BIOGEN MA INC. Patent Application Trends in 2025
- BioTheryX, Inc. Patent Application Trends in 2024
- Blueprint Medicines Corporation Patent Application Trends in 2024
- Blueprint Medicines Corporation Patent Application Trends in 2025
- Board of Regents, The University of Texas System Patent Application Trends in 2024
- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- Boehringer Ingelheim International GmbH Patent Application Trends in 2025
- BOSTON SCIENTIFIC SCIMED, INC. Patent Application Trends in 2024
- Boston Scientific Scimed, Inc. Patent Application Trends in 2024
- BRISTOL-MYERS SQUIBB COMPANY Patent Application Trends in 2024
- BRISTOL-MYERS SQUIBB COMPANY Patent Application Trends in 2025
C
- C4 Therapeutics, Inc. Patent Application Trends in 2025
- Case Western Reserve University Patent Application Trends in 2024
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE Patent Application Trends in 2025
- CHIESI FARMACEUTICI S.P.A. Patent Application Trends in 2025
- Cornell University Patent Application Trends in 2024
D
G
H
J
M
- Mayo Foundation for Medical Education and Research Patent Application Trends in 2025
- MEDSHINE DISCOVERY INC. Patent Application Trends in 2024
- MEMORIAL SLOAN-KETTERING CANCER CENTER Patent Application Trends in 2024
- MEMORIAL SLOAN-KETTERING CANCER CENTER Patent Application Trends in 2025
- MERCK PATENT GMBH Patent Application Trends in 2025
N
- NeuPharma, Inc Patent Application Trends in 2024
- New York University Patent Application Trends in 2025
- NEW YORK UNIVERSITY Patent Application Trends in 2025
- Nimbus Saturn, Inc. Patent Application Trends in 2025
- NIPPON SHINYAKU CO., LTD. Patent Application Trends in 2025
- NOVARTIS AG Patent Application Trends in 2025
- Novartis AG Patent Application Trends in 2025
P
R
S
T
- THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- The Board of Regents of the University of Texas System Patent Application Trends in 2024
- THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2024
- The Johns Hopkins University Patent Application Trends in 2024
- The regents of the university of california (20240245693). COMPOSITIONS AND METHODS OF TISSUE REGENERATION THERAPY simplified abstract
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2025
- The Regents of the University of California patent applications on July 25th, 2024
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2025
- The Regents of the University of Michigan Patent Application Trends in 2025
- The University of British Columbia Patent Application Trends in 2025
- TUFTS MEDICAL CENTER, INC. Patent Application Trends in 2024